Mingbin Zheng

Guangdong Medical College, Chinese Academy of Sciences

Papers

3

Total Citations

169

H-Index

2

About

Mingbin Zheng is a leading researcher at the intersection of micro/nanorobotics, immunotherapy, and bioactive materials, with a focus on engineering living systems for precision medicine. His most impactful work introduces “Magnetic–Acoustic Sequentially Actuated CAR T Cell Microrobots” (84 citations), a groundbreaking platform that combines magnetic guidance with acoustic propulsion to navigate CAR T cells through solid tumors—overcoming the immunosuppressive barriers that have long limited immunotherapy’s success in solid cancers. In another highly cited study (83 citations), Zheng developed “Twin-bioengine self-adaptive micro/nanorobots,” which use enzyme-powered yeast microrobots and macrophage relays to autonomously navigate the gastrointestinal tract for targeted inflammation therapy, demonstrating unprecedented self-adaptive capabilities in complex biological environments. He also contributed to a major review in *Advanced Materials* (2021) on cell/bacteria-based bioactive materials for cancer immune modulation, highlighting his role in shaping the field of bioinspired precision therapy. With over 160 citations across his key papers, Zheng’s work is defining a new paradigm in which living cells are engineered into intelligent, navigable therapeutic robots—offering transformative potential for treating solid tumors and inflammatory diseases.

Research Focus

Key Achievements

2
H-Index
3
Papers
169
Total Citations
56
Avg Citations/Paper
🏆 Most Cited Paper
Magnetic–Acoustic Sequentially Actuated CAR T Cell Microrobots for Precision Navigation and In Situ Antitumor Immunoactivation
84 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Guangdong Medical College, Chinese Academy of Sciences

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago